Previous Close | 197.51 |
1-Year Change | -5.46% |
6-Months Change | 17.5% |
3-Months Change | 26.98% |
Moving Avg (50d) | 178.32 |
Moving Avg (200d) | 164.86 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 267.2B |
Beta (3-Years) | 1.2 |
Revenue Growth (ttm) | 76.38% |
Net Profit Margin (ttm) | -43.52% |
Return On Assets (ttm) | -17.37% |
EPS (ttm) | -0.72 |
PE Ratio (ttm) | -274.32 |
Dividend Yield | % |
Asset Description: | BeiGene, Ltd. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-09-16 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
201.46 | 207.385 | 211.336 | 217.261 | 227.136 | 237.012 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.